Css LLC Ionis Pharmaceuticals Inc Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $331,756 - $453,836	-9,605 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $3.77 Million - $5.65 Million	-88,630 Reduced 90.22%	9,605 $432,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $4.83 Million - $5.85 Million	89,646 Added 1043.73%	98,235 $5.93 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $358,257 - $437,661	6,066 Added 240.43%	8,589 $515,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $286,421 - $397,363	-4,613 Reduced 64.64%	2,523 $162,000
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $138,759 - $173,773	3,236 Added 82.97%	7,136 $368,000
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $325,739 - $407,475	-8,037 Reduced 67.33%	3,900 $163,000
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $543,849 - $711,087	11,937	11,937 $605,000

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.66B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.